Antiplatelet therapy: Ticagrelor in ACS - What does PLATO teach us?

Nature Reviews Cardiology

Volumn 6, Issue 12, 2009, Pages 737-738

  Bhatt, Deepak L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICAGRELOR; TICLOPIDINE;

ACUTE CORONARY SYNDROME; BLEEDING; CHEMICALLY INDUCED DISORDER; HUMAN; MORTALITY; NOTE; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADENOSINE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL TRIALS, PHASE III AS TOPIC; HEMORRHAGE; HUMANS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TICLOPIDINE; TREATMENT OUTCOME;

EID: 75549086129     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2009.192     Document Type: Short Survey

References (10)

1. wallentin, L. et al. for the PLATO investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 361, 1045-1057 (2009
2. Bhatt, D. L. & Topol, e. J. scientific and therapeutic advances in antiplatelet therapy. Nat. Rev. Drug Discov. 2, 15-28 (2003
3. Yusuf, s. et al. for the CURe Trial investigators. effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without sT-segment elevation. N. Engl. J. Med. 345, 494-502 (2001
4. wiviott, s. D. et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 357, 2001-2015 (2007
5. Bhatt, D. L. is prasugrel superior to clopidogrel for patients with acute coronary syndromes undergoing PCi?. Nat. Clin. Pract. Cardiovasc. Med. 5, 252-253 (2008
6. Bhatt, D. L. Prasugrel in clinical practice. N. Engl. J. Med. 361, 940-942 (2009
7. CAPRie steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRie). Lancet 348, 1329-1339 (1996
8. steinhubl, s. R. et al. early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288, 2411-2420 (2002
9. Bavry, A. A. & Bhatt, D. L. Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. Lancet 371, 2134-2143 (2008
10. Bhatt, D. L. Tailoring antiplatelet therapy based on pharmacogenomics: how well do the data fit?. JAMA 302, 896-897 (2009